| [1] |
Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023[J]. CA Cancer J Clin, 2023, 73(1): 17-48. DOI: 10.3322/caac.21763.
|
| [2] |
Han BF, Zheng RS, Zeng HM, et al. Cancer incidence and mortality in China, 2022[J]. J Natl Cancer Cent, 2024, 4(1): 47-53. DOI: 10.1016/j.jncc.2024.01.006.
|
| [3] |
Sepich-Poore GD, Zitvogel L, Straussman R, et al. The microbiome and human cancer[J]. Science, 2021, 371(6536): eabc4552. DOI: 10.1126/science.abc4552.
|
| [4] |
Feng J, Zhao FY, Sun JY, et al. Alterations in the gut microbiota and metabolite profiles of thyroid carcinoma patients[J]. Int J Cancer, 2019, 144(11): 2728-2745. DOI: 10.1002/ijc.32007.
pmid: 30565661
|
| [5] |
Yu XQ, Jiang W, Kosik RO, et al. Gut microbiota changes and its potential relations with thyroid carcinoma[J]. J Adv Res, 2021, 35: 61-70. DOI: 10.1016/j.jare.2021.04.001.
|
| [6] |
Burgess S, Timpson NJ, Ebrahim S, et al. Mendelian randomization: where are we now and where are we going?[J]. Int J Epidemiol, 2015, 44(2): 379-388. DOI: 10.1093/ije/dyv108.
pmid: 26085674
|
| [7] |
Kurilshikov A, Medina-Gomez C, Bacigalupe R, et al. Large-scale association analyses identify host factors influencing human gut microbiome composition[J]. Nat Genet, 2021, 53(2): 156-165. DOI: 10.1038/s41588-020-00763-1.
pmid: 33462485
|
| [8] |
Liu XM, Tong X, Zou YQ, et al. Mendelian randomization analyses support causal relationships between blood metabolites and the gut microbiome[J]. Nat Genet, 2022, 54(1): 52-61. DOI: 10.1038/s41588-021-00968-y.
pmid: 34980918
|
| [9] |
Bowden J, Holmes MV. Meta‐analysis and mendelian randomization: a review[J]. Res Synth Methods, 2019, 10(4): 486-496. DOI: 10.1002/jrsm.1346.
pmid: 30861319
|
| [10] |
Liu Y, Geng R, Liu LJ, et al. Gut microbiota-based algorithms in the prediction of metachronous adenoma in colorectal cancer patients following surgery[J]. Front Microbiol, 2020, 11: 1106. DOI: 10.3389/fmicb.2020.01106.
pmid: 32595614
|
| [11] |
Sun XH, Chen S, Zhao SQ, et al. Causal relationship of genetically predicted gut microbiota with thyroid cancer: a bidirectional two-sample mendelian randomization study[J]. Front Endocrinol (Lausanne), 2024, 15: 1284472. DOI: 10.3389/fendo.2024.1284472.
|
| [12] |
Zhou JT, Zhang X, Xie ZL, et al. Exploring reciprocal causation: bidirectional mendelian randomization study of gut microbiota composition and thyroid cancer[J]. J Cancer Res Clin Oncol, 2024, 150(2): 75. DOI: 10.1007/s00432-023-05535-y.
pmid: 38308705
|
| [13] |
Hu SJ, Tang CG, Wang L, et al. Causal relationship between gut microbiota and differentiated thyroid cancer: a two-sample Mendelian randomization study[J]. Front Oncol, 2024, 14: 1375525. DOI: 10.3389/fonc.2024.1375525.
|
| [14] |
Zhang HB, Yu YH, Li JH, et al. Changes of gut microbiota in colorectal cancer patients with pentatrichomonas hominis infection[J]. Front Cell Infect Microbiol, 2022, 12: 961974. DOI: 10.3389/fcimb.2022.961974.
|
| [15] |
Chen YY, Fei F, Ding LL, et al. Integrated gut microbiome and metabolome analysis reveals the inhibition effect of lactobacillus plantarum CBT against colorectal cancer[J]. Food Funct, 2024, 15(2): 853-865. DOI: 10.1039/d3fo04806c.
|
| [16] |
Lu Y, Cui AX, Zhang XB. Commensal microbiota-derived metabolite agmatine triggers inflammation to promote colorectal tumorigenesis[J]. Gut Microbes, 2024, 16(1): 2348441. DOI: 10.1080/19490976.2024.2348441.
|
| [17] |
Huang R, Li T, Ni JJ, et al. Different sex-based responses of gut microbiota during the development of hepatocellular carcinoma in liver-specific Tsc1-knockout mice[J]. Front Microbiol, 2018, 9: 1008. DOI: 10.3389/fmicb.2018.01008.
pmid: 29867896
|
| [18] |
Yin ZF, Liu BH, Feng SJ, et al. A large genetic causal analysis of the gut microbiota and urological cancers: a bidirectional mendelian randomization study[J]. Nutrients, 2023, 15(18): 4086. DOI: 10.3390/nu15184086.
|
| [19] |
Senthakumaran T, Moen AEF, Tannæs TM, et al. Microbial dynamics with CRC progression: a study of the mucosal microbiota at multiple sites in cancers, adenomatous polyps, and healthy controls[J]. Eur J Clin Microbiol Infect Dis, 2023, 42(3): 305-322. DOI: 10.1007/s10096-023-04551-7.
|
| [20] |
Zheng CM, Lu F, Chen B, et al. Gut microbiome as a biomarker for predicting early recurrence of HBV‐related hepatocellular carcinoma[J]. Cancer Sci, 2023, 114(12): 4717-4731. DOI: 10.1111/cas.15983.
|
| [21] |
Gonçalves MFM, Pina-Vaz T, Fernandes ÂR, et al. Microbiota of urine, glans and prostate biopsies in patients with prostate cancer reveals a dysbiosis in the genitourinary system[J]. Cancers (Basel), 2023, 15(5): 1423. DOI: 10.3390/cancers15051423.
|
| [22] |
Richard ML, Liguori G, Lamas B, et al. Mucosa-associated microbiota dysbiosis in colitis associated cancer[J]. Gut Microbes, 2018, 9(2): 131-142. DOI: 10.1080/19490976.2017.1379637.
pmid: 28914591
|
| [23] |
Hakozaki T, Nolin-Lapalme A, Kogawa M, et al. Cancer cachexia among patients with advanced non-small-cell lung cancer on immunotherapy: an observational study with exploratory gut microbiota analysis[J]. Cancers (Basel), 2022, 14(21): 5405. DOI: 10.3390/cancers14215405.
|
| [24] |
Ye L, Hou YL, Hu WY, et al. Repressed blautia-acetate immunological axis underlies breast cancer progression promoted by chronic stress[J]. Nat Commun, 2023, 14(1): 6160. DOI: 10.1038/s41467-023-41817-2.
pmid: 37789028
|
| [25] |
Xie GX, Wang XN, Huang FJ, et al. Dysregulated hepatic bile acids collaboratively promote liver carcinogenesis[J]. Int J Cancer, 2016, 139(8): 1764-1775. DOI: 10.1002/ijc.30219.
pmid: 27273788
|
| [26] |
Bansal T, Alaniz RC, Wood TK, et al. The bacterial signal indole increases epithelial-cell tight-junction resistance and attenuates indicators of inflammation[J]. Proc Natl Acad Sci U S A, 2010, 107(1): 228-233. DOI: 10.1073/pnas.0906112107.
|
| [27] |
Gao XY, Wang ZG, Liu BW, et al. Causal association of gut microbiota and esophageal cancer: a mendelian randomization study[J]. Front Microbiol, 2023, 14: 1286598. DOI: 10.3389/fmicb.2023.1286598.
|
| [28] |
Liu F, Liu AW, Lu X, et al. Dysbiosis signatures of the microbial profile in tissue from bladder cancer[J]. Cancer Med, 2019, 8(16): 6904-6914. DOI: 10.1002/cam4.2419.
|
| [29] |
Yu DD, Yu XM, Ye AF, et al. Profiling of gut microbial dysbiosis in adults with myeloid leukemia[J]. FEBS Open Bio, 2021, 11(7): 2050-2059. DOI: 10.1002/2211-5463.13193.
pmid: 33993646
|
| [30] |
Zhang ZL, Zhu LH, Ma YQ, et al. Study on the characteristics of intestinal flora composition in gastric cancer patients and healthy people in the Qinghai-Tibet plateau[J]. Appl Biochem Biotechnol, 2022, 194(4): 1510-1526. DOI: 10.1007/s12010-021-03732-4.
|
| [31] |
周名睿, 戚孟琪, 张妍妍, 等. 人体组织中微生物群落与乳腺癌关系的研究进展[J]. 国际肿瘤学杂志, 2024, 51(12): 779-784. DOI: 10.3760/cma.j.cn371439-20240727-00132.
|